1. Ado-trastuzumab emtansine (T-DM1) in HER2+ advanced breast cancer patients: does pretreatment with pertuzumab matter?. (December 2017) Authors: Fabi, Alessandra; Giannarelli, Diana; Moscetti, Luca; Santini, Daniele; Zambelli, Alberto; Laurentiis, Michelino De; Caruso, Michele; Generali, Daniele; Valle, Enrichetta; Leonardi, Vita; Cannita, Katia; Arpino, Grazia; Filippelli, Gianfranco; Ferretti, Gianluigi; Giampaglia, Marianna; Montemurro... Journal: Future oncology Issue: Volume 13:Number 30(2017) Page Start: 2791 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Bilateral spontaneous pneumothorax and massive pneumomediastinum under Pazopanib therapy. Issue 1 (January 2015) Authors: Leuzzi, Giovanni; Alessandrini, Gabriele; Ferraresi, Virginia; Ferretti, Gianluigi; Forcella, Daniele; Facciolo, Francesco Journal: Thoracic cancer Issue: Volume 6:Issue 1(2015) Page Start: 110 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Epidermal growth factor receptor gene copy number may predict lapatinib sensitivity in HER2-positive metastatic breast cancer. (April 2013) Authors: Fabi, Alessandra; Merola, Roberta; Ferretti, Gianluigi; Di Benedetto, Anna; Antoniani, Barbara; Ercolani, Cristiana; Nisticò, Cecilia; Papaldo, Paola; Ciccarese, Mariangela; Sperduti, Isabella; Vici, Patrizia; Marino, Mirella; Gori, Stefania; Botti, Claudio; Malaguti, Paola; Cognetti, Francesco; ... Journal: Expert opinion on pharmacotherapy Issue: Volume 14:Number 6(2013) Page Start: 699 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Functional and pharmacodynamic evaluation of metronomic cyclophosphamide and docetaxel regimen in castration-resistant prostate cancer. (September 2013) Authors: Cardillo, Irene; Spugnini, Enrico P; Galluzzo, Paola; Contestabile, Michela; Dell'Anna, Maria Lucia; Picardo, Mauro; Crispi, Stefania; Calogero, Raffaele A; Piccolo, Maria Teresa; Arigoni, Maddalena; Cantarella, Daniela; Boccellino, Mariarosaria; Quagliuolo, Lucio; Ferretti, Gianluigi; Carlini, P... Journal: Future oncology Issue: Volume 9:Number 9(2013) Page Start: 1375 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Pembrolizumab versus placebo as post-nephrectomy adjuvant therapy for clear cell renal cell carcinoma (KEYNOTE-564): 30-month follow-up analysis of a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial. Issue 9 (September 2022) Authors: Powles, Thomas; Tomczak, Piotr; Park, Se Hoon; Venugopal, Balaji; Ferguson, Thomas; Symeonides, Stefan N; Hajek, Jaroslav; Gurney, Howard; Chang, Yen-Hwa; Lee, Jae Lyun; Sarwar, Naveed; Thiery-Vuillemin, Antoine; Gross-Goupil, Marine; Mahave, Mauricio; Haas, Naomi B; Sawrycki, Piotr; Burgents, Jo... Journal: Lancet oncology Issue: Volume 23:Issue 9(2022) Page Start: 1133 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. T-DM1 and brain metastases: Clinical outcome in HER2-positive metastatic breast cancer. (October 2018) Authors: Fabi, Alessandra; Alesini, Daniele; Valle, Enrichetta; Moscetti, Luca; Caputo, Roberta; Caruso, Michele; Carbognin, Luisa; Ciccarese, Mariangela; La Verde, Nicla; Arpino, Grazia; Cannita, Katia; Paris, Ida; Santini, Daniele; Montemurro, Filippo; Russillo, Michelangelo; Ferretti, Gianluigi; Filipp... Journal: Breast Issue: Volume 41(2018) Page Start: 137 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗